Cannabics Pharmaceuticals stock jumps 12% after filing for patent for CBD modulation of human microbiome
Cannabics Pharmaceuticals Inc. (CNBX), a U.S based public company, announced today it filed the first of several patent applications to cover their work on the use of CBD products for adjusting the microbial populations that live in humans.
The company is pioneering work based on profiling and modulating patient-derived microbiota, thus personalizing and profiling a person’s health status. This will make it possible to tailor and optimize treatments for patients.
The company aims to develop personalized anti-cancer and palliative treatments. Their R&D work is based in Israel, where it is licensed in both scientific and clinical research.
Its stock jumped 12% to $0.84 on the news. The company has a market cap of $99 million, making it roughly the 90th largest company in the cannabis sector.
Source: Cannabics
Cannabics Pharmaceuticals stock jumps 12% after filing for patent for CBD modulation of human microbiome
About Cannin.com: Your Marijuana Stocks Resource
Cannin is your #1 resource for marijuana stocks. Our global team of experts evaluates all emerging marijuana stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana stock investments for 2020.
Use Cannin as your resource for:
- Cannabis and hemp investing news
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Many market analysts expect the legal marijuana industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana stocks is now.
Are you interested in marijuana stocks like Curaleaf, Trulieve, Aurora Cannabis, or Charlotte’s Web,?
Are you looking to buy stock in marijuana companies for 2020? Interested in emerging penny marijuana stocks? Looking for the best Canadian marijuana stocks to invest in? We can help.
Predict price movements of marijuana stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- 108% Backtested since 2012
We’re so confident you’ll love our algotrading marijuana stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best marijuana stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Invest In